Mixed end of the month for the global markets - Monday Review, August 31

Mixed end of the month for the global markets - Monday Review, August 31

The Chinese economy shows signs of recovery

The US

The fact that the Food and Drug Administration (FDA) is fast-tracking three potential #COVID-19 vaccines didn't affect the markets. USA30 lost 0.78%, and USA500 fell 0.22%. TECH100 added 0.68%.

Gold went down 0.05% to $1,974 per ounce.

Oil fell 0.40% to $42.80 per barrel, while Brent Oil slipped 0.11% to $45.55.

The Dollar Index traded 0.22% lower at 91.99, marking the lowest level in more than two years.


Asia and Australia

The benchmarks traded higher, driven by the positive information received from Markit (an independent financial information provider) was seen by investors as signs of an #economic #recovery. HongKong45 rose 1.39%.

Japan225 added 1.89% as the race of appointing a new prime minister has started.

Down under, Australia200 traded 0.11% higher, as the number of new COVID-19 infections reached a two-month low.

USD/JPY traded at 106.10.

AUD/USD gained 0.33% and traded at 0.74.


Europe

The markets reacted in a mixed manner as Brexit talks reached a deadlock. Even though both the European Union and the UK are looking for a deal, that seems to be wishful thinking, as the British prime minister opposes most of the European demands. Europe50 closed down 0.6%. Germany30 fell 0.67%.

UK100 added 1.1%.

EUR/USD rose 0.35% to 1.1945.

EUR/GBP gained 0.21% to 0.8929.

Read all about what happened in August on the financial markets here!

Sources: marketwatch.com, investing.com, express.co.uk

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.